Product image of Mocotac (Acetylcysteine) supplied by GNH India

Mocotac

Active Ingredient:
Acetylcysteine
Origin:
EU

Mocotac (Acetylcysteine)

Acetylcysteine, the active ingredient in Mocotac, is a mucolytic presented as an oral formulation for oral use. It reduces the viscosity of thick respiratory secretions by breaking disulfide bonds in mucus glycoproteins, thereby facilitating expectoration and improving airway clearance in patients with acute bronchitis, chronic obstructive pulmonary disease, cystic fibrosis and other conditions characterized by viscous sputum.

GNH India supplies Mocotac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export.

Manufacturer / TM Owner

Tactica Pharmaceuticals Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mocotac (acetylcysteine) acts on respiratory mucus to improve clearance in several pulmonary conditions.

  • Acute bronchitis: reduces sputum thickness, eases coughing and promotes clearance of mucus in the airways.
  • Chronic obstructive pulmonary disease (COPD): thins viscous secretions, facilitating expectoration and potentially improving airflow limitation.
  • Cystic fibrosis: breaks disulfide bonds in thick mucus, supporting airway hygiene and reducing infection risk.
  • Chronic bronchitis: lowers mucus viscosity, making it easier to expectorate and improving respiratory comfort.

How It Works

  • Acetylcysteine acts as a mucolytic by cleaving disulfide bonds within mucus glycoproteins, which decreases the polymeric network that gives mucus its thickness. The resulting reduction in viscosity enhances mucociliary transport and expectoration. Additionally, acetylcysteine serves as a precursor for intracellular glutathione, helping to restore antioxidant capacity in respiratory epithelial cells. This dual action contributes to improved airway clearance and protection against oxidative stress.

Side Effects

Acetylcysteine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal discomfort
  • Headache
  • Rash

Serious or Rare Side Effects

  • Anaphylactic reaction
  • Severe skin eruptions such as Stevens‑Johnson syndrome
  • Bronchospasm
  • Hepatic dysfunction
  • Neutropenia
  • Renal impairment

Precautions & Warnings

When using Mocotac, several precautionary measures should be observed to ensure safety.

  • Assess renal function: adjust use in patients with severe renal impairment.
  • Monitor hepatic enzymes: watch for signs of liver dysfunction during therapy.
  • Avoid in known hypersensitivity: discontinue immediately if allergic reaction occurs.
  • Use caution in asthma: may provoke bronchospasm, especially with inhaled formulations.
  • Pregnancy and lactation: consult a healthcare professional before use.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Acetylcysteine can interact with other medicines, influencing their efficacy or safety profile.

Major Interactions (Avoid)

  • Nitroglycerin: concurrent use may cause marked hypotension.
  • Carbapenem antibiotics (e.g., imipenem): increased risk of rash and allergic reactions.
  • Chemotherapeutic agents that rely on glutathione: may alter drug metabolism.
  • Warfarin: potential enhancement of anticoagulant effect, requiring close monitoring.

Moderate Interactions (Monitor Closely)

  • Bronchodilators (e.g., β2‑agonists): may enhance bronchodilatory response.
  • ACE inhibitors: monitor blood pressure for additive hypotensive effect.
  • Diuretics: observe electrolyte balance, especially potassium levels.

Frequently Asked Questions

Mocotac contains acetylcysteine and is indicated for respiratory disorders where thick mucus is a problem. It is commonly used in acute bronchitis, chronic obstructive pulmonary disease (COPD), cystic fibrosis and chronic bronchitis to help thin secretions and improve expectoration.

Acetylcysteine breaks disulfide bonds within mucus glycoproteins, disrupting the polymeric structure that makes mucus viscous. This chemical cleavage lowers mucus thickness, enhances mucociliary clearance, and also replenishes intracellular glutathione, supporting antioxidant defenses in the airway epithelium.

The appropriate dose of Mocotac is determined by the prescribing clinician based on the patient’s age, weight, renal function and the specific respiratory condition being treated. Dosage regimens are individualized and should follow the prescriber’s instructions on the product label.

Safety data for acetylcysteine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should be consulted before initiating therapy in pregnant or nursing women.

To request Mocotac, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both acetylcysteine (Mocotac) and carbocisteine act as mucolytics, but acetylcysteine directly cleaves disulfide bonds, leading to a more rapid reduction in mucus viscosity. Carbocisteine modifies mucus structure indirectly. Clinical choice depends on patient tolerance, specific indication, and physician preference.

Mocotac should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and excessive heat to maintain stability and potency.

Mocotac is taken orally, usually as a tablet or liquid formulation, according to the prescriber’s directions. It can be swallowed with water and may be taken with or without food, depending on the specific product instructions.

Serious adverse reactions, although rare, include anaphylactic shock, severe skin reactions such as Stevens‑Johnson syndrome, bronchospasm, hepatic dysfunction, neutropenia and renal impairment. Patients should seek immediate medical attention if they experience signs of these conditions.

Mocotac should be avoided in individuals with known hypersensitivity to acetylcysteine or any excipients in the formulation. Caution is also advised for patients with severe asthma, uncontrolled renal or hepatic disease, and those taking medications that may interact significantly without proper monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Acetylcysteine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT